Chemoinformaics analysis of DIHYDROYASHABUSHIKETOL
| Molecular Weight | 282.383 | nRot | 8 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 13 |
| Exact Molecular Weight | 282.162 | nRing | 2 |
| Solubility: LogS | -3.785 | nHRing | 0 |
| Solubility: LogP | 2.988 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 48.0034 |
| nHD | 1 | BPOL | 22.9386 |
| QED | 0.803 |
| Synth | 2.225 |
| Natural Product Likeliness | 0.946 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.917 |
| Pgp-sub | 0.997 |
| HIA | 0.042 |
| CACO-2 | -4.704 |
| MDCK | 0.0000193 |
| BBB | 0.768 |
| PPB | 0.952248 |
| VDSS | 0.875 |
| FU | 0.0109011 |
| CYP1A2-inh | 0.664 |
| CYP1A2-sub | 0.548 |
| CYP2c19-inh | 0.91 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.705 |
| CYP2c9-sub | 0.262 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.285 |
| CYP3a4-inh | 0.056 |
| CYP3a4-sub | 0.582 |
| CL | 12.313 |
| T12 | 0.849 |
| hERG | 0.15 |
| Ames | 0.083 |
| ROA | 0.014 |
| SkinSen | 0.59 |
| Carcinogencity | 0.151 |
| EI | 0.833 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.54783 |